We are live on ! Find out more
GSK icon

GSK
GSK

813 hedge funds and large institutions have $10B invested in GSK in 2022 Q4 according to their latest regulatory filings, with 168 funds opening new positions, 235 increasing their positions, 275 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more call options, than puts

Call options by funds: $420M | Put options by funds: $157M

110% more first-time investments, than exits

New positions opened: 168 | Existing positions closed: 80

28% more capital invested

Capital invested by funds: $7.84B → $10B (+$2.2B)

23% more funds holding in top 10

Funds holding in top 10: 13 → 16 (+3)

10% more funds holding

Funds holding: 742 → 813 (+71)

0.22% more ownership

Funds ownership: 6.57% → 6.78% (+0.22%)

15% less repeat investments, than reductions

Existing positions increased: 235 | Existing positions reduced: 275

Holders
813
Holders Change
+71
Holders Change %
+9.57%
% of All Funds
13.07%
Holding in Top 10
16
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+23.08%
% of All Funds
0.26%
New
168
Increased
235
Reduced
275
Closed
80
Calls
$420M
Puts
$157M
Net Calls
+$263M
Net Calls Change
+$44.5M

Top Buyers

Rank Fund Capital Flow
1
JEST
JTC Employer Solutions Trustee
Jersey
+$442M
2
Dodge & Cox
Dodge & Cox
California
+$211M
3
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$200M
4
Primecap Management
Primecap Management
California
+$111M
5
Nomura Holdings
Nomura Holdings
Japan
+$69.4M

Top Sellers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
-$326M
2
Two Sigma Investments
Two Sigma Investments
New York
-$219M
3
Renaissance Technologies
Renaissance Technologies
New York
-$100M
4
Citadel Advisors
Citadel Advisors
Florida
-$92.5M
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$77.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
AAA
826
Affinity Asset Advisors
New York
– -$2.21M -75,000 Closed
Hudson Bay Capital Management
827
Hudson Bay Capital Management
Connecticut
– -$2.21M -75,000 Closed
SCP
828
Stamos Capital Partners
California
– -$2.02M -68,530 Closed
Parallax Volatility Advisers
829
Parallax Volatility Advisers
California
– -$2.24M -67,337 Closed
TPM
830
Triasima Portfolio Management
Quebec, Canada
– -$1.86M -63,260 Closed
Verition Fund Management
831
Verition Fund Management
Connecticut
– -$1.86M -55,959 Closed
ZAM
832
Zevin Asset Management
Massachusetts
– -$1.58M -53,806 Closed
BBL
833
Beck Bode LLC
Massachusetts
– -$961K -32,666 Closed
ACM
834
Aquatic Capital Management
Illinois
– -$889K -30,200 Closed
FAIM
835
Financial Advocates Investment Management
Washington
– -$3.2M -27,563 Closed
BDWCC
836
B&D White Capital Company
Texas
– -$810K -27,530 Closed
PAWC
837
P.A.W. Capital
Connecticut
– -$809K -27,500 Closed
BAM
838
Blueshift Asset Management
New Jersey
– -$696K -23,640 Closed
Tudor Investment Corp
839
Tudor Investment Corp
Connecticut
– -$681K -23,126 Closed
FWM
840
Foresight Wealth Management
Utah
– -$650K -22,077 Closed
MCM
841
Mork Capital Management
California
– -$545K -18,504 Closed
FA
842
FDx Advisors
Illinois
– -$467K -15,864 Closed
MAM
843
Marotta Asset Management
Virginia
– -$464K -15,754 Closed
NWM
844
Northcape Wealth Management
New York
– -$413K -14,024 Closed
MA
845
MUFG Americas
New York
– -$396K -13,443 Closed
CPA
846
Cardiff Park Advisors
California
– -$324K -11,008 Closed
Bank of Nova Scotia
847
Bank of Nova Scotia
Ontario, Canada
– -$324K -11,000 Closed
JWCA
848
J.W. Cole Advisors
Florida
– -$288K -9,795 Closed
AT
849
Arvest Trust
Oklahoma
– -$284K -9,656 Closed
AIP
850
Almanack Investment Partners
Pennsylvania
– -$273K -9,280 Closed
32 33
34
35 36

GSK Hedge Fund Activity: Q4 2022 in Review

813 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in GSK (GSK) for Q4 2022, worth a combined $10B — up 28% from $7.84B a quarter earlier.

Buyers outnumbered sellers: 168 funds opened new GSK positions and 80 closed out — a net gain of 88 holders — while 235 added to existing stakes and 275 trimmed.

The largest buyer was JTC Employer Solutions Trustee, adding an estimated $442M. The largest seller was Capital International Investors, exiting entirely with an estimated $326M sold.

  • 813 institutional investors held GSK (GSK) as of Q4 2022, up from 742 in Q3 2022.
  • Funds reported $10B of GSK stock for Q4 2022, up 28% quarter-over-quarter.
  • 168 funds opened new GSK positions in Q4 2022 and 80 closed out, a net change of +88 holders.
  • The largest GSK buyer in Q4 2022 was JTC Employer Solutions Trustee, an estimated $442M added.
  • The largest GSK seller in Q4 2022 was Capital International Investors, an estimated $326M sold.

Based on aggregated 13F filings for Q4 2022.